|
At Novartis, we are committed to advancing the treatment of CML and other cancers. Every day, we work to discover new and unique medicines and treatments that can improve and extend the lives of people with CML and other cancers. Novartis regularly conducts medical and pharmaceutical research via clinical trials. We do this as part of our ongoing commitment to innovation and discovery. Learn more about CML research and Novartis' commitment to develop therapies that target Ph+ CML. |
